Literature DB >> 12608536

Influence of spacer length on interaction of mannosylated liposomes with human phagocytic cells.

Andreas Engel1, Swapan Kumar Chatterjee, Ali Al-arifi, Dagmar Riemann, Jürgen Langner, Peter Nuhn.   

Abstract

PURPOSE: To improve target specificity and uptake of liposomes by macrophages, one can improve high-affinity receptor binding to mannose determinants with their 175-kDa mannose receptor (MR), which is mainly influenced by the length and flexibility of the spacer between the carbohydrate head group and liposome surface. Liposomes containing alkylmannosides with hydrophilic spacers 0 to 8 ethyleneoxy units (EO) long (Man0...Man8) were used to investigate systematically the effects of spacer length on liposome-cell interactions.
METHODS: Concanavalin A (ConA)-induced liposome aggregation was studied by turbidity measurement and cell uptake using PMA-induced HL-60 cells or native human macrophages by determining 6-CF after cell lysis or NBD-fluorescence with flow cytometry. Detection of MR in native cell populations was carried out by an antibody assay using flow cytometry; MR-representing cells were selected analytically.
RESULTS: Liposomes containing mannosides with more than one EO spacer length were specifically aggregated by ConA, indicating accessibility of the carbohydrate ligands of these derivatives. Increase in EO spacer units of incorporated mannosides (two or more EO) led to suppression of cellular uptake of mannosylated liposomes by phagocytes lacking MR (HL60, U937). The extent of suppression increased with spacer length. Liposome uptake by native macrophages expressing MR was, on the contrary, improved, particularly by Man6 and Man8.
CONCLUSIONS: Uptake of liposomes modified with Man6 or Man8 by native cells was enhanced but did not reach an optimum. Thus, Man6, Man8, and mannosides with even longer spacer arms are of potential use in receptor-mediated targeting.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12608536     DOI: 10.1023/a:1022294624256

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  35 in total

1.  An extended conformation of the macrophage mannose receptor.

Authors:  C E Napper; M H Dyson; M E Taylor
Journal:  J Biol Chem       Date:  2001-02-08       Impact factor: 5.157

2.  Involvement of serum mannan binding proteins and mannose receptors in uptake of mannosylated liposomes by macrophages.

Authors:  P Opanasopit; Y Higuchi; S Kawakami; F Yamashita; M Nishikawa; M Hashida
Journal:  Biochim Biophys Acta       Date:  2001-03-09

Review 3.  Non-carbohydrate binding partners/domains of animal lectins.

Authors:  H J Gabius
Journal:  Int J Biochem       Date:  1994-04

4.  Enhanced gene transfection in macrophages using mannosylated cationic liposome-polyethylenimine-plasmid DNA complexes.

Authors:  A Sato; S Kawakami; M Yamada; F Yamashita; M Hashida
Journal:  J Drug Target       Date:  2001-06       Impact factor: 5.121

5.  Monoclonal antibodies against the human mannose receptor as a specific marker in flow cytometry and immunohistochemistry for macrophages.

Authors:  F Noorman; E A Braat; M Barrett-Bergshoeff; E Barbé; A van Leeuwen; J Lindeman; D C Rijken
Journal:  J Leukoc Biol       Date:  1997-01       Impact factor: 4.962

6.  Inhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers.

Authors:  Praneet Opanasopit; Megumi Sakai; Makiya Nishikawa; Shigeru Kawakami; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  J Control Release       Date:  2002-04-23       Impact factor: 9.776

7.  Studies on the effective size of phospholipid headgroups in bilayer vesicles using lectin-glycolipid interaction as a steric probe.

Authors:  R Sundler
Journal:  Biochim Biophys Acta       Date:  1984-03-28

8.  Ligand recognition by purified human mannose receptor.

Authors:  V Kéry; J J Krepinský; C D Warren; P Capek; P D Stahl
Journal:  Arch Biochem Biophys       Date:  1992-10       Impact factor: 4.013

9.  Uptake of neoglycoproteins via membrane lectin(s) of L1210 cells evidenced by quantitative flow cytofluorometry and drug targeting.

Authors:  M Monsigny; A C Roche; P Midoux
Journal:  Biol Cell       Date:  1984       Impact factor: 4.458

10.  Synthetic glycolipids and the lectin-mediated aggregation of liposomes.

Authors:  G A Orr; R R Rando; F W Bangerter
Journal:  J Biol Chem       Date:  1979-06-10       Impact factor: 5.157

View more
  10 in total

1.  Optimization of cell receptor-specific targeting through multivalent surface decoration of polymeric nanocarriers.

Authors:  Suzanne M D'Addio; Steven Baldassano; Lei Shi; Lila Cheung; Douglas H Adamson; Matthew Bruzek; John E Anthony; Debra L Laskin; Patrick J Sinko; Robert K Prud'homme
Journal:  J Control Release       Date:  2013-02-16       Impact factor: 9.776

2.  Impact of tether length on bone mineral affinity of protein-bisphosphonate conjugates.

Authors:  Sébastien A Gittens; Pavel I Kitov; John R Matyas; Raimar Löbenberg; Hasan Uludağ
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

3.  Targeted liposomal drug delivery to monocytes and macrophages.

Authors:  Ciara Kelly; Caroline Jefferies; Sally-Ann Cryan
Journal:  J Drug Deliv       Date:  2010-10-26

Review 4.  Nanotechnology: intelligent design to treat complex disease.

Authors:  Patrick Couvreur; Christine Vauthier
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.580

5.  Transferrin-conjugated liposomes loaded with novel dihydroquinoline derivatives as potential anticancer agents.

Authors:  Mengqiao Wang; Robert J Lee; Ye Bi; Lianlian Li; Guodong Yan; Jiahui Lu; Qingfan Meng; Lesheng Teng; Jing Xie
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

6.  Glycyrrhetinic Acid Liposomes Containing Mannose-Diester Lauric Diacid-Cholesterol Conjugate Synthesized by Lipase-Catalytic Acylation for Liver-Specific Delivery.

Authors:  Jing Chen; Yuchao Chen; Yi Cheng; Youheng Gao
Journal:  Molecules       Date:  2017-09-24       Impact factor: 4.411

7.  Optimization of the Linker Length of Mannose-Cholesterol Conjugates for Enhanced mRNA Delivery to Dendritic Cells by Liposomes.

Authors:  Fazhan Wang; Wen Xiao; Mostafa A Elbahnasawy; Xingting Bao; Qian Zheng; Linhui Gong; Yang Zhou; Shuping Yang; Aiping Fang; Mohamed M S Farag; Jinhui Wu; Xiangrong Song
Journal:  Front Pharmacol       Date:  2018-09-05       Impact factor: 5.810

8.  Conjugation of Mannans to Enhance the Potency of Liposome Nanoparticles for the Delivery of RNA Vaccines.

Authors:  Roshan Goswami; Derek T O'Hagan; Roberto Adamo; Barbara C Baudner
Journal:  Pharmaceutics       Date:  2021-02-09       Impact factor: 6.321

9.  Characterization of functional mannose receptor in a continuous hybridoma cell line.

Authors:  David J Vigerust; Sherell Vick; Virginia L Shepherd
Journal:  BMC Immunol       Date:  2012-09-12       Impact factor: 3.615

10.  A drug delivery strategy: binding enkephalin to asialoglycoprotein receptor by enzymatic galactosylation.

Authors:  Michelle P Christie; Pavla Simerská; Freda E-C Jen; Waleed M Hussein; Mohamad F M Rawi; Lauren E Hartley-Tassell; Christopher J Day; Michael P Jennings; Istvan Toth
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.